Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > I finally put Juansito on Ignore

<< Previous

Bullboard Posts

Next >>

Comment by 12joem88on Jul 12, 2018 1:16am

110 Views

Post# 28304168

RE:RE:I finally put Juansito on Ignore

Guys, you can call Juanito a pumper or whatever, I don’t think he cares. I came to ICO because of him. He may write and sound different but you have to read between the lines. He is telling you something. Anyway, he has been around ICO longer than all of us combine. So if he is a pumper, he has great stamina since he has been doing this for 10 years. Salutations. Joe

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale